Ever since the ongoing pandemic outbreak started many researchers and Pharmaceutical companies across the globe are not leaving any stone unturned to come up with a vaccine for the virus.
In the wake of the tough situation, Pharmaceutical pioneer Pfizer came up with a piece of good news that by the end of October a potential vaccine that can cure the virus can be readied.
The Global Pharmaceutical firm has been conducting clinical trials for the vaccine in the US and Europe which collaborated with a German Company. Both the firms were been testing the BNT162 vaccine to fight the pandemic.
Albert Bourla, CEO of Pfizer confirmed the same who recently participated in a virtual event that is organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
The CEO said that if everything goes well they have all the required evidence to confidently say that they will come up with a potential vaccine to treat the pandemic.
In the wake of the tough situation, Pharmaceutical pioneer Pfizer came up with a piece of good news that by the end of October a potential vaccine that can cure the virus can be readied.
The Global Pharmaceutical firm has been conducting clinical trials for the vaccine in the US and Europe which collaborated with a German Company. Both the firms were been testing the BNT162 vaccine to fight the pandemic.
Albert Bourla, CEO of Pfizer confirmed the same who recently participated in a virtual event that is organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
The CEO said that if everything goes well they have all the required evidence to confidently say that they will come up with a potential vaccine to treat the pandemic.